Target therapy (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Target therapy (unspecified), covering 2025-02-13 to 2025-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy [Phase 2]